Neoadjuvant Immunotherapy in Advanced cSCC

Vishal Patel

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Year in Review: Bowen Diseases and Squamous Cell Carcinoma of the Na…

Dermatology 2024 Year in Review

J. Dominguez-Cherit

Year in Review 2024 - Cutaneous Squamous Cell Carcinoma and Basal Ce…

Oncology 2024 Year in Review

G. In

Update in Treatment of Advanced Non-Melanoma Skin Cancers

Cleveland Clinic Dermatology & Plastic Surgery Institute

A. Vij

AAD 2024 Insights: What's New In Nail Tumors

AAD Insights

J. Dominguez-Cherit

Updated in The Treatment of Immune-Related Adverse Events of Immunot…

Cleveland Clinic Dermatology & Plastic Surgery Institute

L. Korb Ferris

Advancements in Merkel Cell Carcinoma: Role of Immunotherapy and New…

Roswell Park Comprehensive Cancer Center

M. Wong

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero

Updates on Neoadjuvant IO for Non-Melanoma Skin Cancer

Neil Gross

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

Oncolytic Viral Therapies in the Treatment of Melanoma and Other Ski…

Melanoma Research Foundation

G. In

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy…

Siddhartha Baxi

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

How Do You Undertake a Multidisciplinary Approach to SCC Management?

dermsquared

L. Korb Ferris

Neoadjuvant IO: Non-Melanoma Skin Cancer

ImmunoTherapy Bridge 2023

N. Gross

54 y/o Female With Merkel Cell Carcinoma: Case Discussion

Winship Melanoma and Cutaneous Oncology Symposium

Z. Buchwald, M. Faries, H. Ilyas, S. Patel

Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Prof. Chalid Assaf

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Insights from 2023 ESMO Annual Meeting

N. Gross